The results of CPL’36 – PDE10a inhibitor to be presented in the poster session at Neuroscience 2021.

This year, from November 8-11, the jubilee, 50th edition of the conference organized by the Society for Neuroscience - the world's largest organization of scientists and doctors dealing with brain diseases will take place.

Despite the fact that the event is planned in the online formula, the organizers have planned numerous lectures, poster sessions and discussions with researchers, as well as plenty of shows and exhibitions of the latest technologies from industrial exhibitors.

During the event, Mikołaj Matłoka, Leader of the Neuropsychiatria Research Group at Celon Pharma S.A. will present a poster:

CPL500036 - a novel inhibitor of phosphodiesterase 10A - attenuates parkinsonian-like and L-DOPA induced dyskinetic effects in 6-OHDA lesioned rats

M. Matloka, T. Lenda, K. Ossowska, K. Berghauzen-Maciejewska, D. Biała, A. Gajos-Draus, P. Pankiewicz, K. Mulewski, A. Janusz, D. Smuga, M. Górka, J. Pieczykolan, M. Wieczorek, J. Konieczny;

The presentation of the poster will take place on November 11, 2021 from 4:00 p.m. to 5:00 p.m.